Arcus agrees to buy SK Pharma from Syz Capital and Saturnus Capital
Thursday, October 1, 2026 · first reported by PE Hub
Arcus acquires SK Pharma, a Bielefeld-based operator of eight temperature-controlled pharmaceutical warehouses in northwest Germany, from sponsors Syz Capital and Saturnus Capital.
- Firm
- Arcus
- Also named
- SK Pharma, Syz Capital, Saturnus Capital
- Asset class
- Private equity
- Geography
- Europe
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.
Coverage
1 source- Sycamore Partners agrees $8.9bn Boots exit to Wittington InvestmentsPE Hub +3
- Elliott, Siris weigh $2bn-plus sale of GigamonHedgeweek
- CVC ups Recordati take-private offer to €10.5bn after shareholder pushbackPrivate Equity Wire
- Old Ironsides, EnCap Flatrock’s Brazos seals $4.4bn Midland asset sale to ONEOKPE Hub
- Blackstone agrees $3.0bn sale of events business Clarion to InformaPE Hub
- Lovell Minnick, Carlyle AlpInvest-backed SRS Acquiom agrees to Pantarai acquisitionPE Hub